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The study was presented to the Gastroenterology
Society of Australia Annual meeting (Australian
Gastro Week) in August 2017 and published in the
abstracts of the Journal of Gastroenterology and
Hepatology Volume 32, Issue S2, August 2017,
Pages: 190–197, Version of Record online:
17 August 2017, DOI: 10.1111/jgh.13900. Data on
symptom changes in subsets of the patients were
presented at the American Gastroenterology
Abstract
Background and Aim: Polyethylene glycol (PEG) is the gold standard for fecal dis-
impaction in constipation. A regimen of PEG combined with the stimulant laxative
sodium picosulphate (SPS) produced fecal disimpaction in chronically constipated
children in the community, but it is unknown if it is effective for more severe consti-
pation. To determine the stool output and effect of a combined PEG and SPS regimen
on fecaloma in children with severe constipation and impaction.
Methods: Children with symptoms for a duration of ≥2 years, a palpable fecaloma,
and enlarged rectum on X-ray (rectal: pelvic ratio > 0.6) were recruited from a ter-
tiary hospital. Daily diaries recorded laxative dose, stool frequency, volume, and
consistency (Bristol stool scale, BSS). Abdominal X-rays were taken on day 1 and
day 8, and stool loading was assessed using the Leech score. Laxative doses were
based on the child’s age. The dose of PEG with electrolytes taken was 2–8 sachets
(14.7 g/sachet) on days 1–2, reducing to 2–6 sachets on day 3. The SPS dose was
15–20 drops on days 2–3.
Results: Eighty-nine children (4–18 years) produced a large volume of soft stool
(median/inter-quartile-range: 2.2/1.6–3.1 L) over 7 days. Stool volume on X-rays
decreased signiﬁcantly in the colon (P < 0.001). Fecalomas resolved in 40 of 89 chil-
dren, while 49 needed a second high dose. Rectal:pelvic ratios did not change.
Conclusions: A combined high dose of PEG and SPS on days 1 and 2 was effective
in removing the fecaloma in half of the children. Administering high doses for a lon-
ger period should be tested to provide outpatient disimpaction for severe fecalomas.
Rectums remained ﬂaccid after emptying.
doi:10.1002/jgh3.12062
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Introduction
Chronic constipation is common in pediatrics, representing 3–5% of
general outpatient visits and up to 25% of gastroenterology consulta-
tions.1 The prevalence of constipation in children has been estimated
to range between 1 and 30%.2,3 Treatments include dietary, pharma-
cological approaches (laxatives, prokinetics), behavioral therapy,
and, in extreme cases, surgery.4–6 Fecal impaction is deﬁned as
accumulation of hard stool in the anorectum.7,8 Disimpaction, to
remove the hard fecal mass, is required before commencing mainte-
nance therapy for constipation.
Polyethylene glycol (PEG) 3350 is an osmotic laxative that
draws water into the colon to soften the stool. It is an oxyethylene
polymer (H[OCH2CH2]3350OH) that cannot be absorbed or
metabolized by the body.9 PEG disimpacted 92% of children in
randomized control trials (RCTs) and was signiﬁcantly more
effective than a placebo.10,11 In these clinical trials, the maximum
high dose for each age (1.5 g/kg/day) was given for 3–6 days,
although many patients developed incontinence, suggesting that
the dose was too high.
Bisacodyl and its derivative sodium picosulphate (SPS)
are stimulant laxatives that are effective but produce cramping
in some patients. As SPS is a liquid, it is more easily taken by
children and is more easily titrated.12 SPS is a locally acting
laxative of the triarylmethane group, which undergoes bacterial
cleavage in the colon to produce a diphenol, which stimulates
bowel motility. SPS and bisacodyl have a similar level of effec-
tiveness and, alone, can produce disimpaction in 80% of
children.12,13
A large volume of PEG is required for disimpaction, and
this can result in poor compliance, but adding a stimulant can
halve the volume of PEG required and increase compliance.14,15
PEG with a stimulant has also been used to completely empty
the bowel prior to colonoscopy16 in individuals with normal
bowel motility. These ﬁndings can translate into regimens for
disimpaction. In this study, we tested a method of combining
PEG with SPS for disimpaction in children,17 aiming to deter-
mine its effectiveness in children with severe, chronic constipa-
tion and a palpable fecaloma.
Methods
A total of 120 patients (4–18 years of age) from the community
or those presenting to The Royal Children’s Hospital Emergency
Department with chronic constipation were enrolled. Patients
were screened by history, and those who met the criteria were
assessed by a Pediatric Gastroenterologist (ML) for a palpable
fecaloma. If a fecaloma was present, they were X-rayed and
then educated on how to do the disimpaction and the dose of
laxatives to take. Fecal disimpaction was performed by
patients as the ﬁrst step in a RCT testing another intervention.
All patients underwent disimpaction followed by 3 weeks of
education on diet, stress, when to toilet, and toilet posture.
Patients completed a daily diary that was used to record laxa-
tive volume taken, stool volume produced, stool frequency,
and consistency measured with the Bristol stool scale (BSS).
Study data were collected and managed using the REDCap
electronic data capture tools hosted at The Murdoch Chil-
dren’s Research Institute.18 Research Electronic Data Capture
(REDCap) is a secure, web-based application designed to sup-
port data capture for research studies. This study is a review
of the abdominal X-rays and diary records of the ﬁrst week.
Data on symptoms have been previously reported in abstracts.19,20
X-rays were taken to determine fecal loading and the rectal:pel-
vic ratio before (day 1) and 1 week (day 8) after oral laxatives.
Inclusion criteria were: ≥2 years’ chronic constipation deﬁned
by Rome III criteria21; palpable fecaloma on presentation, con-
ﬁrmed by palpation by an experienced clinician; an enlarged
stool-ﬁlled rectum on X-ray; and a rectal:pelvic ratio above the
normal range (>0.61).
The laxatives given included PEG plus electrolytes
(Movicol, Norgine, 14.7 g/sachet) and SPS (Dulcolax SP drops,
Boehringer, 7.5 mg/mL, 0.5 mg/drop).22 The prescribed dose is
shown in Table 1. The maximum PEG dose/day approved by
Therapeutic Goods Association, TGA, Australia varies by age (4
sachets for 4 to 5 years, 6 sachets for 6 to 11 years and 8 sachets
for 12 years and older). Patients were prescribed the maximum
dose for their age on day 1, reducing on day 2 and 3, and then
again to 1 sachet on day 4–7. Each sachet was dissolved in
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125 mL water plus an equal volume of juice/milk. Children
drank 125–250 mL per half hour over the morning, making it
easier to drink small volumes each hour and spreading the ﬂuid
intake. They took 10–20 drops of SPS (dose dependent on age)
in a drink at night, as described previously, starting on day
2, with the highest dose given on day 3. SPS was not started on
day 1 to avoid producing pain by using a stimulant while the
fecaloma was still hard. Delaying SPS by a day gave the PEG a
chance to soften the stool. If disimpaction was not achieved, a
second round of high-dose laxatives was given on days 8–10.
Stool loading on X-rays was measured by three observers
using the Leech scoring method.23 The Leech method divides the
colon into three regions (right, left, and rectosigmoid/rectum),
and each region is scored as follows: 0, no feces; 1, scant feces;
2, mild fecal loading; 3, moderate fecal loading; 4, severe fecal
loading; and 5, severe fecal loading with bowel dilatation. Stool
volume on X-rays was estimated by outlining segments of colon
and measuring the length and radius; then, volume was
calculated using the following equation for a cylinder, where “r”
is the radius of the colon (half the width) and “L” is the length of
the colon segment: Volume of a cylinder = πr2 × L. The volume
of multiple segments was summed to obtain the total colon
volume.
Ethical approval was obtained from the Murdoch Chil-
dren’s Research Institute (MCRI) and The Royal Children’s Hos-
pital (RCH), Melbourne, Australia (HREC 32014, 33132,
35151). The institutional ethics committee approved the study in
accordance with international standards (including the Declara-
tion of Helsinki). All participants gave informed consent prior to
their inclusion in the study. The study was supported by the
National Health and Medical Research Council (NHMRC), Pro-
ject Grant (1025726) 2012–2015; clinical trial registration—
ACTRN12612001009808.
Results
A total of 120 patients were enrolled from April 2013 to May
2015. Ninety-nine commenced disimpaction. Six patients com-
pleted diary entries for fewer than 5 days in the disimpaction
week, and so, their data were not analyzed. Ninety-four patients
ﬁlled in diaries for 6 or 7 days, but data were available for both
X-rays from only 89 patients (43 male, median age 8 years
[range 4–18]). All patients had constipation and treatment for
≥2 years (2–10 years). Sixteen patients also had diary data col-
lected for the 2 weeks before treatment. The frequency of bowel
motions was a median of 6.5 (IQR 3, 11) per week before treat-
ment, and median stool volume produced was 1.0 (IQR 0.73,
Table 1 Prescribed dose of Movicol (polyethylene glycol [PEG] and
electrolytes 14.7 g/sachet) and Dulcolax SPS (drops 0.5 mg/drop)
Age (years) Day 1 Day 2 Day 3 Day 4
Movicol sachets 4–5 4 2–3 1–2 1
6–11 6 5–6 2–3 1
12–18 6–8 4–8 2–3 1
SPS drops 4–11 — 12 15 10
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Figure 1 Dose of laxatives and stool output per day. (a) Dose of polyethylene glycol (PEG) plus electrolytes taken. One sachet =14.7 g. (b) Dose of
stimulant sodium picosulphate (SPS) drops taken. (c) Volume of stool (liters) produced. Stool volume was estimated by patients/parents.
(d) Softness of stool estimated using the Bristol Stool Scale (BSS), where 1 is very hard and 7 is very soft. (n = 89, median, range).
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1.63) L/week. None of the patients had <3 bowel movements/
week, with the lowest being 3.
All patients had a palpable fecaloma conﬁrmed by two
study clinicians and a rectal diameter:pelvic internal diameter (R:
P) ratio above the normal range (0.63–0.96, median 0.84). The
extent of hard stool was estimated by palpation. On day 1, most
patients had hard stool palpable beyond the rectum, three quar-
ters had hard stool in the sigmoid, one third into the descending
colon, and 1 had hard stool all the way to the transverse colon.
The volume of stool in the colon was estimated from the X-rays
and was between 0.05 and 1.7 L on day 1.
The prescribed dose of Movicol was based on the age of the
patients (Table 1). Some did not take the prescribed dose. The
median dose of Movicol and Dulcolax taken each day is shown in
Figure 1a,b. Patients took 2–8 sachets of PEG on day 1, 2–6 sachets
on day 2, and 1–6 sachets on day 3. They then commenced a main-
tenance dose on days 4–7, with the dose starting at 1 sachet and
ranging from 0 to 6 sachets (Fig. 1a). Patients were prescribed























































































Figure 2 Volume of stool on X-rays. Volume of stool measured in X-rays in (a) total colon and (b) each region: right colon (RC), left colon (LC); recto-
sigmoid (RS). Stool loading in X-ray using the Leech Score in the (c) total colon and (d) each region. ****P < 0.0001, ***P < 0.001. Relationship of
stool volume on X-ray to Leech Score on (e) day 1 and (f ) day 8. (n = 89, mean, SEM).
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0 drops of SPS on day 1. Most patients took no SPS on day 1 (but
11 patients took 10–20 drops), 15 drops on day 2, and 15–20 drops
on day 3 and then 10 drops on days 4–7 (Fig. 1b). The variation in
dose on days 4–7 indicates patients increasing or decreasing the
dose if they felt they needed to.
Prior to treatment, patients were taking a range of laxa-
tives, including Osmolax, Movicol, Dulcolax, Lactulose, Para-
choc, and Coloxyl. Despite this, they were heavily impacted.
Most patients produced <1 cup (250 mL) of stool on day
1 (median 160 mL, Fig. 1c), with stool volumes peaking on day
2 and day 3. The stool volume then decreased on day 4, and
patients continued to produce stool over 7 days. Stool consis-
tency became softer (median BSS 4–6, P < 0.001). The increase
in stool volume and softness occurred on day 2, the day after the
ﬁrst large dose of PEG and before any SPS was taken (on the
evening of day 2). Over 7 days, they produced a median of 2.2
(IQR 1.6, 3.1) L of stool. In the 16 patients with baseline data,
median stool frequency increased from 7 per the week before to
19 (IQR 13, 30)/week during the disimpaction week. Twenty-
eight (of 89) patients produced <0.5 L of stool over the 7 days,
and 17 (61%) of these required a second disimpaction.
Soiling is commonly a problem in children with chronic
constipation and is a common worry for patients using disimpac-
tion doses of PEG. This regimen did not produce much soiling,
with patients averaging less than 1 day of soiling in the week
(data not shown).
Data for X-ray measures and all days of the diaries were
available for 89 patients. Day 1 X-rays conﬁrmed large stool
masses in the rectosigmoid (stool volume in X-ray, median 0.28 L
IQR 0.19, 0.36, Fig. 2a,b), with a Leech score indicating signiﬁ-
cant fecal loading (median 4.0, IQR 3.4, 4.3, Fig. 2c,d and mean
 SEM rectal:pelvic ratio of 0.84  0.01, Fig. 3). Three people
independently scored the fecal loading using the Leech scoring
system.23 Intraobserver consistency was very good to excellent
[Intraclass Correlation Coefﬁcient (ICC) 0.82–0.96], and interob-
server agreement was fair to good (ICC 0.54). There was a signiﬁ-
cant reduction in the volume of stool in the right colon, left
colon, rectosigmoid, and in the whole colon both by volume
estimate (Fig. 2a,b) and by the Leech score (Fig. 2c,d). The
Leech score and volume of stool on X-ray showed a positive















Figure 3 Rectal:Plevic ratio on day 1 and day 8. (n = 89, mean, SEM).
Day 1 Day 8
Day 8Day 1
R2 = 0.05 R2 = 0.05


































































Figure 4 Relationship of X-ray stool volume and stool output over 7 days. For total colon on (a) day 1 and (b) day 8. For rectosigmoid on (c) day
1 and (d) day 8.
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Forty patients had no palpable fecaloma on day 8 and
were classiﬁed as achieving disimpaction. Forty-nine patients
required a second round of high-dose laxatives for 2–3 days after
day 8 and then achieved disimpaction. There was a weak positive
relationship between stool volume on X-ray and volume of stool
produced (Fig. 4). There was little relationship between stool vol-
ume in the X-ray and PEG dose (Fig. 5c,d).
We expected that the patients requiring a second disimpac-
tion might have more stool to move. To determine if there was a
difference in the X-ray volume of the two groups (one round of
laxatives versus two rounds of laxatives), we compared the vol-
ume of stool in the rectosigmoid (Fig. 5). As expected, there was
a signiﬁcantly higher volume of stool in the rectosigmoid on day
8 in the group that required a second dose of laxatives for disim-
paction (Fig. 5a,b). However, the volume range of the two
groups overlapped both before and after the disimpaction, with
only seven patients in the group requiring a second high dose of
laxatives having a really high stool volume (>1 L) in the day
8 X-ray (Fig. 5c,d).
Although the total stool volume in the whole colon was
reduced, the R:P ratios (Fig. 3) did not change after disimpaction.
Discussion
PEG is the gold-standard laxative treatment for constipation as it
is well investigated,24,25 safe and effective, and suitable for
chronic use. The effect is dose dependent,26 with the main side
effect being abdominal bloating24 due to distension of the bowel
because of water binding.27 Previous studies used maximal doses
for 3 or 6 days.10,11 SPS is also effective for disimpaction, and
studies for colonoscopy bowel preparation have shown that add-
ing a stimulant laxative allows the volume of PEG to be reduced.
We previously tested combined PEG and SPS for disimpaction
in children in a suburban clinic.17 The aim of the current study
was to determine the effect of the same treatment in children
with more severe constipation and fecal impaction (symptoms
for ≥2 years, palpable fecaloma with enlarged rectum proven by
abdominal X-ray, rectal:pelvic ratio of 0.62–0.96).28 Patients
received a high dose of PEG and SPS over 3 days, and this
resulted in increased stool frequency (from 7/week before to
19/week), volume, and improved stool softness. The hard feca-
loma was completely removed in half of the patients.
PEG with electrolytes may be difﬁcult to drink due to the
large volume, salty taste, or the gritty texture.29 Kierkus et al.
found that children were more likely to require insertion of a
nasogastric tube if they were required to drink large volumes of
PEG solution, compared to low-volume PEG plus a stimulant
laxative.30 We developed a method to overcome many of the
compliance issues (add the child’s favorite drink to cover the ﬂa-
vor, divide the dose into 250 mL aliquots, use small glasses, and
make it a fun race).
A recent study compared two doses of PEG for chronic
constipation (high 0.7 g/kg and low 0.3 g/kg over 6 weeks).31
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Figure 5 Volume of stool on X-ray in patients requiring one or two rounds of high-dose laxatives to achieve disimpaction. (a,b) volume of stool in
X-ray in rectosigmoid (RS) for whole group (total) and for group disimpacted after one round of high-dose laxatives (1 disimp, n = 40) or two rounds
of high-dose laxatives (2 disimp, n = 49). A: Median, range. (c,d) comparison of stool volume on X-ray on day 1 and dose of Movicol taken over
7 days. (c) Group requiring one round of disimpaction and (d) group requiring two rounds of disimpaction.
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adjustment to therapy, and more children experienced painful defe-
cation.31 Children in the current study were given 2–8 sachets of
PEG (0.9–1.5 g/kg on day 1–2, reducing to 0.3 g/kg on day 3).
The treatment produced large volumes of stool and reduced fecal
load, but half of the patients required a second round of disimpac-
tion, suggesting inadequate dosing. Rather than reducing the dose
each day, it may be necessary to keep the dose of PEG high until
a deﬁned end-point of stool volume or wetness is reached. We pre-
viously reported this method for treating patients attending a sub-
urban clinic where successful disimpaction was higher. The
difference in results is likely to be due to the patients in the current
study having more severe symptoms (and strict entry criteria).
Using plain abdominal radiography in diagnosing constipa-
tion is contentious, with no association between clinical symptoms
of constipation and fecal loading in the radiograph.32,33 The degree
of fecal loading in abdominal X-rays is affected by recent bowel
movements emptying the rectum and ﬂuctuations in diet.34 NASP-
GHAN guidelines recommend an abdominal X-ray if there is fecal
impaction.35 As the inclusion criteria for this study required that
all patients have a palpable fecaloma (i.e. were impacted), it was
felt it was appropriate to use radiography to objectively measure
fecal loading in these patients.
There are three published scoring methods for evaluating
fecal loading in children using abdominal radiography. Barr
et al. used the quantity and quality of stool in the colon to score
the fecal load.36 Blethyn et al. graded constipation solely based
on the distribution of stool through the colon.37 Leech et al.23
(used in this study) divided the colon into three regions and
scored each region separately from 0 to 5 based on the visible
fecal load. All methods demonstrated high intraobserver correla-
tion, while the Leech method has the strongest interobserver
correlation.23,38–40 High correlations between the Leech score
and BSS, colonic transit time, and gastrointestinal symptoms
have been demonstrated in constipated children.38 In this study,
there was excellent correlation for intraobserver scoring, and the
interobserver ICC was fair to moderate, suggesting that the use
of the Leech system was valid.
It is well established that children with chronic constipation
develop an enlarged rectum. However, the relationship between
constipation and megarectum is still disputed, and the presence of
an enlarged rectum reveals nothing about the pathophysiology of
the constipation.28 Although the disimpaction method was able to
empty the rectum, there was no change in the rectal:pelvic ratio,
suggesting that acute disimpaction did not result in a toned rectum.
This is consistent with the current literature proposing that rever-
sion of the rectum back to its normal size takes months or years,
and the ﬂaccid rectum reﬁlls immediately. This is likely to be an
ongoing problem and suggests that further interventions that target
the rectal tone are needed to produce a strong and narrower
section of bowel.
It is interesting that the stool frequency started initially
above two defecations per week. Patients were on laxatives
and were still impacted. Dinning et al.41 also reported that
adults with chronic constipation take laxatives and have
>2 defecations/week.
The study was limited by no comparator group because
patients were part of a RCT where all patients had disimpac-
tion before being randomized to two treatment groups. Pre-
disimpaction diary data were only available for a subset of
patients as many wanted to start disimpaction straight away
and did not ﬁll diaries before disimpaction. The Leech measure
of volume of stool in X-rays is not validated, and clinicians
disagree on the usefulness of X-rays to measure stool and how
to identify the outline of the empty bowel. All the patients in
this study had impacted rectums, which made it easier to deﬁne
the outline of the bowel, but many images were hard to iden-
tify. The volume of laxatives taken and stool output volumes
were estimates by patients/parents who were shown a small
adult ﬁst as an example of a “cup” size (250 mL). It is difﬁcult
to estimate a volume for very watery stool.
In conclusion, disimpaction is difﬁcult in patients with an
impacted rectum and chronic constipation. Using PEG at the
maximum dose for age on day 1 and reducing the dose over days
2 and 3, combined with SPS, produced a large volume of stool
on days 2–3 and resolved fecalomas in half of the patients, sug-
gesting that the method is effective for some, but a longer period
on the high dose of PEG is needed for some patients with severe
impaction. The method resulted in high levels of compliance, but
maintaining higher doses for a longer period should be tested in
these difﬁcult patients. Effective disimpaction improves symp-
toms but does not reduce rectal diameter.
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